Filing Details
- Accession Number:
- 0001179110-12-017433
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-12-12 17:12:17
- Reporting Period:
- 2012-12-10
- Filing Date:
- 2012-12-12
- Accepted Time:
- 2012-12-12 17:12:17
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1800 | Abbott Laboratories | ABT | Pharmaceutical Preparations (2834) | 360698440 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1501589 | David A. Forrest | 100 Abbott Park Road Abbott Park IL 60064 | Senior Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares Without Par Value | Acquisiton | 2012-12-10 | 5,700 | $52.54 | 40,715 | No | 4 | M | Direct | |
| Common Shares Without Par Value | Acquisiton | 2012-12-10 | 6,200 | $55.56 | 46,915 | No | 4 | M | Direct | |
| Common Shares Without Par Value | Acquisiton | 2012-12-10 | 9,568 | $51.74 | 56,483 | No | 4 | M | Direct | |
| Common Shares Without Par Value | Acquisiton | 2012-12-10 | 13,867 | $46.60 | 70,350 | No | 4 | M | Direct | |
| Common Shares Without Par Value | Disposition | 2012-12-10 | 47,286 | $65.10 | 23,064 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Shares | Option (right to buy) | Acquisiton | 2012-12-10 | 5,700 | $0.00 | 5,700 | $52.54 |
| Common Shares | Option (right to buy) | Acquisiton | 2012-12-10 | 6,200 | $0.00 | 6,200 | $55.56 |
| Common Shares | Option (right to buy) | Acquisiton | 2012-12-10 | 9,568 | $0.00 | 9,568 | $51.74 |
| Common Shares | Option (right to buy) | Acquisiton | 2012-12-10 | 13,867 | $0.00 | 13,867 | $46.60 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2010-02-16 | 2017-02-15 | No | 4 | M | Direct |
| 0 | 2011-02-15 | 2018-02-14 | No | 4 | M | Direct |
| 4,782 | 2012-09-17 | 2020-09-16 | No | 4 | M | Direct |
| 27,733 | 2012-02-18 | 2021-02-17 | No | 4 | M | Direct |
Footnotes
- Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.
- Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.
Billionaire Hedge Funds
